Lista publikacji:

  1. Grimaldi R, Gibson GR, Vulevic J, Giallourou N, Castro-Mejía JL, Hansen LH, Leigh Gibson E, Nielsen DS, Costabile A. A prebiotic intervention study in children with autism spectrum disorders (ASDs). Microbiome. 2018;6(1):133. doi: 10.1186/s40168-018-0523-3. https://pmc.ncbi.nlm.nih.gov/articles/PMC6091020/pdf/40168_2018_Article_523.pdf
  2. Vulevic J, Tzortzis G, Juric A, Gibson GR. Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence. Neurogastroenterol Motil. 2018 Nov;30(11):e13440. doi: 10.1111/nmo.13440. https://onlinelibrary.wiley.com/doi/10.1111/nmo.13440
  3. Huaman JW, Mego M, Manichanh C, Cañellas N, Cañueto D, Segurola H, Jansana M, Malagelada C, Accarino A, Vulevic J, Tzortzis G, Gibson G, Saperas E, Guarner F, Azpiroz F. Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders. Gastroenterology. 2018 Oct;155(4):1004-1007. doi: 10.1053/j.gastro.2018.06.045. https://www.gastrojournal.org/article/S0016-5085(18)34687-0/fulltex
  4. Wilson B, Rossi M, Kanno T, Parkes GC, Anderson S, Mason AJ, Irving PM, Lomer MC, Whelan K. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria. Am J Gastroenterol. 2020 Jun;115(6):906-915. doi: 10.14309/ajg.0000000000000641. https://journals.lww.com/ajg/abstract/2020/06000/__galactooligosaccharide_in_conjunction_with_low.20.aspx
  5. Wilson B, Eyice Ö, Koumoutsos I, Lomer MC, Irving PM, Lindsay JO, Whelan K. Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms. Nutrients. 2021 Oct 14;13(10):3598. doi: 10.3390/nu13103598. https://www.mdpi.com/2072-6643/13/10/3598
  6. Wilson B, Kanno T, Slater R, Rossi M, Irving PM, Lomer MC, Probert C, Mason AJ, Whelan K. Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Aliment Pharmacol Ther. 2023 Aug;58(4):404-416. doi: 10.1111/apt.17609. https://onlinelibrary.wiley.com/doi/10.1111/apt.17609